Bico Group AB

Bico Group AB is an SME in Goteborg, Sweden that has taken part in 11 EU-funded projects since 2016, receiving €4.3M in EU funding and leading 1 as coordinator.

EU funding received€4.3M
EU projects11
As coordinator1
Running now1
First EU project2016
Latest project2023
CountrySweden
EU registration (PIC)920200007
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Bico Group AB's own share of each project, not the project's full budget.

  • Horizon 2020€4.3M · 7 projects
  • Horizon Europe€0 · 4 projects

Projects

11 EU-funded projects, newest first. Bico Group AB led 1 of them as coordinator. Each links to the official record.

  • iRETINAAssociated partner

    Development of a multilayered and bioprinted iPSC-derived retinal model with use in preclinical and toxicological testing

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

  • OpenMINDPartner

    Opto-Electronic Neural Connectoid Model Implemented for Neurodegenerative Disease

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

  • PRISM-LTPartner

    PRInted Symbiotic Materials as a dynamic platform for Living Tissues production

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

  • BioProSPartner

    Biointelligent Production Sensor to Measure Viral Activity

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

  • LIFESAVERPartner

    Living Impact on Fetal Evolution: Shelter-Analyze-Validate-Empower Regulations

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

  • TRiAnklePartner

    3D BIOPRINTED PERSONALISED SCAFFOLDS FOR TISSUE REGENERATION OF ANKLE JOINT

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €479ktheir share
  • REPAIRPartner

    RESTORING CARDIAC MECHANICAL FUNCTION BY POLYMERIC ARTIFICIAL MUSCULAR TISSUE

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €270ktheir share
  • GIOTTOPartner

    Active aGeIng and Osteoporosis: The next challenge for smarT nanobiOmaterials and 3D technologies

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €300ktheir share
  • TUMOURPRINTCoordinator

    High Throughput Bioprinting of Tumour Models for Drug Development and Oncology Research

    Horizon 2020 · 2018–2021 · Project on CORDIS ↗

    €2.5Mtheir share
  • SilkFUSIONPartner

    Genetically engineered human pluripotent stem cells, functionalized silk-fibroin platforms and bio-inks: a novel solution for large-scale ex-vivo platelet production, transfusion and drug research

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €344ktheir share
  • CENSUSPartner

    Cell-Based Models for Neurodegeneration Study and Use in Screening

    Horizon 2020 · 2016–2019 · Project on CORDIS ↗

    €453ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • additive manufacturing
  • anatomy and morphology
  • bacteriology
  • biomaterials
  • biomolecules
  • cardiology
  • census
  • dementia
  • drug discovery
  • embryology
  • fetal medicine
  • gene therapy
  • immunology
  • implants

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime